Right now it looks also to me, that already controlled buying is going on, since days large buy orders get filled.
After Phase 2 trial and then NEU will be very big on the agenda and some of the big Pharma Companies to become part from it. Might we see also first takeover approches.
Neu is working on the Neutral regeneration peptides and methods for their use in treatment of brain damage, traumatic brain injury.
Sofar has been no announcement but expected unless they announce that the trials that should have already started, actually have. More recently developments since 1.July: - Neuren received US$14mill funding from the US Armee, total of US$18.7mill - Costs for the phase 2 trial to be funded by the US Armee - Total US Armee funding represents A$0.09 per share non- dilutive funding !!! - US FDA approves for phase 2 trial - US FDA grants "Fast Track" status
